Scribe Therapeutics Inc.
Support and Resistance Levels
Past performance
News About SCTX
All events for SCTX
All deals for SCTX
Financial Ratios
Financial Statements
SCTX vs Sector & Peers
About Scribe Therapeutics Inc.
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention. Website scribetx.com
Headquarters Alameda, CA, US